Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Nephrology
Spironolactone Fails To Improve CV Outcomes In Patients With Stage 3b Chronic Kidney Disease: Study
0 Comments
Post a comment
No comments yet. Be the first to comment!